BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24124115)

  • 1. Multiple tumor types including leiomyoma and Wilms tumor in a patient with Gorlin syndrome due to 9q22.3 microdeletion encompassing the PTCH1 and FANC-C loci.
    Garavelli L; Piemontese MR; Cavazza A; Rosato S; Wischmeijer A; Gelmini C; Albertini E; Albertini G; Forzano F; Franchi F; Carella M; Zelante L; Superti-Furga A
    Am J Med Genet A; 2013 Nov; 161A(11):2894-901. PubMed ID: 24124115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gorlin syndrome with an ovarian leiomyoma associated with a PTCH1 second hit.
    Akizawa Y; Miyashita T; Sasaki R; Nagata R; Aoki R; Ishitani K; Nagashima Y; Matsui H; Saito K
    Am J Med Genet A; 2016 Apr; 170A(4):1029-34. PubMed ID: 26782978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdeletion of 9q22.3: A patient with minimal deletion size associated with a severe phenotype.
    Ewing AD; Cheetham SW; McGill JJ; Sharkey M; Walker R; West JA; West MJ; Summers KM
    Am J Med Genet A; 2021 Jul; 185(7):2070-2083. PubMed ID: 33960642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple nevoid basal cell carcinoma syndrome associated with congenital orbital teratoma, caused by a PTCH1 frameshift mutation.
    Rodrigues AL; Carvalho A; Cabral R; Carneiro V; Gilardi P; Duarte CP; Puente-Prieto J; Santos P; Mota-Vieira L
    Genet Mol Res; 2014 Jul; 13(3):5654-63. PubMed ID: 25117323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From gene to disease: basal cell naevus syndrome].
    de Meij TG; Baars MJ; Gille JJ; Hack WW; Haasnoot K; van Hagen JM
    Ned Tijdschr Geneeskd; 2005 Jan; 149(2):78-81. PubMed ID: 15688838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microdeletion 9q22.3 syndrome includes metopic craniosynostosis, hydrocephalus, macrosomia, and developmental delay.
    Muller EA; Aradhya S; Atkin JF; Carmany EP; Elliott AM; Chudley AE; Clark RD; Everman DB; Garner S; Hall BD; Herman GE; Kivuva E; Ramanathan S; Stevenson DA; Stockton DW; Hudgins L
    Am J Med Genet A; 2012 Feb; 158A(2):391-9. PubMed ID: 22190277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of microdeletion 9q22.3 (pat).
    Shimojima K; Adachi M; Tanaka M; Tanaka Y; Kurosawa K; Yamamoto T
    Clin Genet; 2009 Apr; 75(4):384-93. PubMed ID: 19320658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ameloblastoma associated with the nevoid basal cell carcinoma (Gorlin) syndrome.
    Eslami B; Lorente C; Kieff D; Caruso PA; Faquin WC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jun; 105(6):e10-3. PubMed ID: 18417377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel PTCH1 Frameshift Mutation Leading to Nevoid Basal Cell Carcinoma Syndrome.
    Durmaz CD; Evans G; Smith MJ; Ertop P; Akay BN; Tuncalı T
    Cytogenet Genome Res; 2018; 154(2):57-61. PubMed ID: 29544218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation.
    Kijima C; Miyashita T; Suzuki M; Oka H; Fujii K
    Fam Cancer; 2012 Dec; 11(4):565-70. PubMed ID: 22829011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTCH1 and SMO gene alterations in keratocystic odontogenic tumors.
    Sun LS; Li XF; Li TJ
    J Dent Res; 2008 Jun; 87(6):575-9. PubMed ID: 18502968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel PTCH1 mutations in Japanese Nevoid basal cell carcinoma syndrome patients: two familial and three sporadic cases including the first Japanese patient with medulloblastoma.
    Fujii M; Noguchi K; Urade M; Muraki Y; Moridera K; Kishimoto H; Hashimoto-Tamaoki T; Nakano Y
    J Hum Genet; 2011 Apr; 56(4):277-83. PubMed ID: 21368767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of chromosome 9q22.32q31.1 microdeletion and the nevoid basal cell carcinoma syndrome.
    de Ravel TJ; Ameye L; Ballon K; Borghgraef M; Vermeesch JR; Devriendt K
    Eur J Med Genet; 2009; 52(2-3):145-7. PubMed ID: 19233320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilms' tumor in patients with 9q22.3 microdeletion syndrome suggests a role for PTCH1 in nephroblastomas.
    Isidor B; Bourdeaut F; Lafon D; Plessis G; Lacaze E; Kannengiesser C; Rossignol S; Pichon O; Briand A; Martin-Coignard D; Piccione M; David A; Delattre O; Jeanpierre C; Sévenet N; Le Caignec C
    Eur J Hum Genet; 2013 Jul; 21(7):784-7. PubMed ID: 23169491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhabdomyosarcoma, Wilms tumor, and deletion of the patched gene in Gorlin syndrome.
    Cajaiba MM; Bale AE; Alvarez-Franco M; McNamara J; Reyes-Múgica M
    Nat Clin Pract Oncol; 2006 Oct; 3(10):575-80. PubMed ID: 17019435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome having distinct PTCH1 mutations: a case report.
    Sasaki R; Miyashita T; Matsumoto N; Fujii K; Saito K; Ando T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug; 110(2):e41-6. PubMed ID: 20659694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal desmoplastic medulloblastoma in an african-american child with nevoid basal cell carcinoma (gorlin) syndrome. Case report.
    Smucker PS; Smith JL
    J Neurosurg; 2006 Oct; 105(4 Suppl):315-20. PubMed ID: 17328283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gorlin syndrome patient with large deletion in 9q22.32-q22.33 detected by quantitative multiplex fluorescent PCR.
    Musani V; Cretnik M; Situm M; Basta-Juzbasic A; Levanat S
    Dermatology; 2009; 219(2):111-8. PubMed ID: 19439922
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.